Drug
Protmune
Protmune: highest development phase Phase 1/2, developed by Fate Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Fate Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| ProTmune NCT02743351 | Phase 1/2 | Hematologic Malignancies |
Latest
No recent events.
Follow Protmune on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.